Buy Tamoxifen Citrate from Discount Pharmacy
We are a leading Canadian mail-order pharmacy service focusing on both on prescription cost-containment and patient safety. We only work with a small network of trusted and reputable international pharmacies and fulfillment centers, giving you access to authentic medications at low prices every day. All medications are shipped directly to you from our affiliated licensed international and Canadian pharmacies and fulfillment centers. Our staff are knowledgeable and efficient to ensure that your shopping experience is hassle free. Save on prescription drugs like Tamoxifen Citrate as well as other prescription drugs like Abilify, Avapro, Evista, Lipitor, Nexium, Norvasc, Propecia, Lunesta, Viagra, Zocor.
10 Great Reasons to Choose Our Service!
Live and professional customer service ready to help you order Tamoxifen Citrate.
Your prescription drugs are mailed directly to your home from our licensed Canadian pharmacy in Canada.
Canadian Prescription drugs are non-taxable when you purchase them from Canada.
Friendly and professional customer care reps ready to answer your questions about ordering from our pharmacy service.
There are no duties, taxes or other fees on prescriptions drugs from our pharmacy service.
Orders placed with our Canadian Pharmacy are reviewed by fully licensed Canadian physicians and fully licensed Canadian pharmacists.
All customers have the option to pay by VISA, Master Card, e-cheque, or international money order.
Canadian prescription drugs in Canada are of the same brand, quality, purity and potency as prescription drugs in the USA.
You can save even more when you order generic drugs. Canadian generic prescriptions drugs are the exact same quality and potency as brand name prescriptions drugs, but cost less.
Buying Tamoxifen Citrate from a trusted and well-established online pharmacy service with impeccable delivery.
Why Are Cancer Drugs So Expensive?
The high cost of cancer drugs is related to a number of factors. It is very very expensive to move findings from bench to bedside and to perform all the regulatory studies (from phase 1, 2, and 3 clinical trials) to gain approval. Second, even when the monopoly is broken with the arrival of 'new and improved' versions of an approved drug, the older drug (and by now generic) tends to be viewed as substandard treatment, thereby perpetuating the situation. Third, the very nature of cancer, and the seriousness of the diagnosis, plays a role in that patients and physicians are often willing to pay the high price of treatment even for marginal improvements in outcome. Finally, because most cancers are incurable, patients are treated with each approved agent creating a virtual monopoly because the use of one drug does not automatically mean that the others are no longer needed.